Anika Therapeutics, Inc. ANIK
NASDAQ · United States · Health Technology
$19.10-0.26 (-1.34%)
Market closed· · USD · Data may be delayed
Prices may be delayed and are for informational purposes only - not investment advice.
Market closed· · USD · Data may be delayed
Prices may be delayed and are for informational purposes only - not investment advice.
| Quarter | Report date | Actual EPS | Estimated EPS | EPS surprise | Actual revenue | Revenue surprise | Price reaction |
|---|---|---|---|---|---|---|---|
| Q2 2026 | 2026-07-29 | 0.42 | 0.03 | +1,300.0% | $32.61M | +11.6% | +19.3%$15.15→$18.07 |
| Q1 2026 | 2026-04-29 | -0.24 | -0.21 | -14.3% | — | — | -18.4%$15.26→$12.45 |
| Q4 2025 | 2026-02-26 | 0.13 | -0.19 | +168.4% | — | — | +31.3%$10.94→$14.36 |
| Q3 2025 | 2025-11-05 | -0.17 | -0.19 | +10.5% | — | — | +1.2%$9.63→$9.75 |
| Q1 2025 | 2025-05-09 | -0.06 | 0.09 | -166.7% | — | — | — |
| Q4 2024 | 2025-03-12 | -0.03 | 0.09 | -133.3% | — | — | — |
| Q4 2023 | 2024-03-13 | 0.05 | -0.23 | +121.7% | — | — | — |
The price reaction is the change from the last close before the announcement date to the first close after it - the report may land before the open, during the session or after the close, so this window covers all three. Not investment advice.